The planned investment at the Alexion Campus in College Park, Dublin, is expected to create about 100 direct jobs, including scientist and engineering positions, as well as further indirect jobs.

AstraZeneca has announced that it will be establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, at a cost of over €300m.

Read more here.